𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mo1697 Risk of Pneumocystis Jiroveci Pneumonia Among Patients With Inflammatory Bowel Disease

✍ Scribed by Long, Millie D.; Farraye, Francis A.; Okafor, Philip N.; Martin, Christopher F.; Sandler, Robert S.; Kappelman, Michael

Book ID
122242996
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
119 KB
Volume
142
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prophylaxis against Pneumocystis pneumon
Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: Toward a standard of care
✍ David M. Poppers; Ellen J. Scherl πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 105 KB

Patients with Crohn's Disease and ulcerative colitis are increasingly treated with a host of immunomodulatory and immunosuppressive medications, including thiopurines and antibody-based biologic agents. Despite the known infectious complications associated with these therapies from the HIV and solid